Kognitic, Inc.

We are headed to ASH 2025 in Orlando from December 6 - 9! Over the next two weeks we will be sharing clear, data driven insights from the hematology landscape to help teams prepare for the meeting. Our team reviewed the abstract trends for ASH 2025 in Kognitic and several themes stand out. • Phase II is the center of gravity this year → Mid stage development represents half of all ASH mapped oncology and immunology trials, reflecting a cycle focused on de risking and sharpening pivotal readiness. • Small molecules continue to anchor hematology development → Small molecule programs represent the largest share of industry sponsored activity across the dataset, especially within B cell and myeloid programs. • CAR-T has evolved into a core modality → The maturity and volume of CAR T programs indicate that it has moved from experimental to established, with next wave constructs and combinations advancing through development. • Q2 and Q3 2025 show strong trial momentum at ASH → A clear uptick in new trial initiations first presenting this year, signaling a busy readout season ahead and a highly competitive landscape for differentiation. • Bi-specifics and ADCs remain high growth areas → These modalities continue to expand within hematology portfolios as companies look for scalable and differentiated approaches. If you are attending ASH and would like to compare your focus areas against the broader landscape, our team will be available to connect during the meeting. We look forward to seeing everyone in sunny Orlando! 🌞🌴 #ASH2025 #Hematology #Oncology #ClinicalTrials #DrugDevelopment #LifeSciences #Biotech #Pharma #MedicalAffairs #ClinicalDevelopment #CompetitiveIntelligence #PipelineStrategy #TherapeuticDevelopment #DataDrivenInsights #Kognitic

Stop wasting three weeks manually reconciling clinical data post-congress. Work from a live, continuously updated competitive landscape.

Chicago changes the competitive landscape overnight. New readouts. Shifted timelines. Endpoints that rewrite positioning. Kognitic structures it all before you get back to the office. Clinical trial intelligence and evidence benchmarking in one platform, built for the teams making portfolio decisions. See it live at our booth.

Chicago changes the competitive landscape overnight. New readouts. Shifted timelines. Endpoints that rewrite positioning. Kognitic structures it all before you get back to the office. Clinical trial intelligence and evidence benchmarking in one platform, built for the teams making portfolio decisions. See it live at our booth.

Chicago changes the competitive landscape overnight. New readouts. Shifted timelines. Endpoints that rewrite positioning. Kognitic structures it all before you get back to the office. Clinical trial intelligence and evidence benchmarking in one platform, built for the teams making portfolio decisions. See it live at our booth.

Chicago changes the competitive landscape overnight. New readouts. Shifted timelines. Endpoints that rewrite positioning. Kognitic structures it all before you get back to the office. Clinical trial intelligence and evidence benchmarking in one platform, built for the teams making portfolio decisions. See it live at our booth.